Biosig Technologies 

$6.1
46
+$1.65+37.08% Thursday 20:00

Statistics

Day High
6.12
Day Low
4.36
52W High
14.11
52W Low
0.23
Volume
3,025,590
Avg. Volume
1,079,920
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

6NovExpected
Q1 2024
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.36
-0.25
-0.15
-0.04
Expected EPS
-0.04
Actual EPS
N/A

Financials

-26,282.5%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
40,000Revenue
-10.51MNet Income

Analyst Ratings

9Average Price Target
The highest estimate is 9.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BSGM. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Abbott Laboratories
ABT
Mkt Cap155.82B
Abbott Laboratories offers a broad range of medical devices, including electrophysiology products, directly competing with Biosig's PURE EP system.
Medtronic
MDT
Mkt Cap102.71B
Medtronic is a major player in the medical device industry, with a strong presence in the cardiac and electrophysiology market, competing with Biosig's technologies.
Baxter International
BAX
Mkt Cap8.88B
Baxter International develops and manufactures medical devices that compete in the broader medical equipment space, including areas that overlap with Biosig's market.
Boston Scientific
BSX
Mkt Cap83.97B
Boston Scientific Corporation specializes in the development of medical devices that are used in interventional medical specialties, including electrophysiology, competing with Biosig.
Johnson & Johnson
JNJ
Mkt Cap546.9B
Johnson & Johnson, through its medical devices segment, competes in the electrophysiology market, offering products that could be seen as alternatives to Biosig's offerings.
Siemens
SIEGY
Mkt Cap228.8B
Siemens Healthineers operates in the medical technology space with a focus on imaging, diagnostics, and advanced therapies that can compete with Biosig's technology in diagnostics and monitoring.
GE Aerospace
GE
Mkt Cap299.35B
General Electric, through its healthcare division, offers medical imaging and monitoring products that compete in the broader medical device market, including areas relevant to Biosig.
Koninklijke Philips N.V.
PHG
Mkt Cap24.89B
Philips is a diversified technology company with a strong healthcare segment offering products in imaging, patient monitoring, and diagnostics that compete with Biosig's technologies.
Hologic
HOLX
Mkt Cap16.97B
Hologic specializes in diagnostics, medical imaging systems, and surgical products that compete in the broader medical device and diagnostics market.
Stryker
SYK
Mkt Cap112.88B
Stryker Corporation is involved in the development of medical devices, including surgical and neurotechnology products, that compete in the broader market for medical equipment.

About

BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial fibrillation, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.
Show more...
CEO
Mr. Ferdinand Groenewald
Employees
5
Country
United States
ISIN
US09073N2018

Listings

0 Comments

Share your thoughts

FAQ

What is Biosig Technologies stock price today?
The current price of BSGM is $6.1 USD — it has increased by +37.08% in the past 24 hours. Watch Biosig Technologies stock price performance more closely on the chart.
What is Biosig Technologies stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Biosig Technologies stocks are traded under the ticker BSGM.
Is Biosig Technologies stock price growing?
BSGM stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Biosig Technologies has showed a +326.57% increase.
What is Biosig Technologies revenue for the last year?
Biosig Technologies revenue for the last year amounts to 40,000 USD.
What is Biosig Technologies net income for the last year?
BSGM net income for the last year is -10.51M USD.
How many employees does Biosig Technologies have?
As of May 06, 2026, the company has 5 employees.
In which sector is Biosig Technologies located?
Biosig Technologies operates in the Health & Wellness sector.
When did Biosig Technologies complete a stock split?
The last stock split for Biosig Technologies was on February 02, 2024 with a ratio of 1:10.
Where is Biosig Technologies headquartered?
Biosig Technologies is headquartered in Los Angeles, United States.